Rehab Mindanao1The Dangerous Drugs Board-TRCC Team visited the two government rehabilitation centers in Mindanao last August 7-9, 2014 to look into the status of the rehab centers which is being financially assisted by the Board. The team was headed by Asec. Amador S. Pabustan, DDB Deputy Executive Director for Administration, with Atty. Philip Josef Vera Cruz, Ms. Melanie Castillo, Mr. Rommel San Pedro and Ms. Perlita Odulio as members.

In Cagayan De Oro, the group was welcomed by Dr. Benson Go, Center Director of Cagayan de Oro Treatment and Rehabilitation Center. Dr. Go expressed his gratitude for the continuous support of the Board to their rehab center.

The monitoring team noted the on-going construction of a 2-phase building facility.  Based on their observations, the facilities in CDO Treatment and Rehab Center were well-kept, clean and orderly. All patients are in good condition and their needs are well-addressed.Rehab Mindanao2

During the visit, the DDB Monitoring team also discussed with CDO Rehab Center and Northern Mindanao Medical Center Officials issues on liquidation and the handling of financial assistance from DDB.

The team also headed to Iligan City for the monitoring of Iligan City Treatment and Rehabilitation Center and noted the following: 1) the center facilities are slightly deteriorating, some of the door beams are rotten to the core, 2) All the fixtures and faucets are no longer working, 3) There is no water supply, and 4) center was already built 5 years ago and still not yet operational. The team decided that in case the City Government stands pat on its decision not to have the Center operate, funding assistance will be transferred to the DOH for management.  

In its report, the team indicated that financial assistance granted by the Board to the above-mentioned centers were used for construction and maintenance of the facilities.

Rehab Mindanao3The Board is mandated to support the establishment of government operated rehabilitation centers as provided for under Republic Act No. 9165, also known as The Comprehensive Dangerous Drugs Act of 2002.